Search research articles
Contact Us
Filters
Showing results (391-400 of 419) with videos related to
Page
of 42
Sort By:
Journal for Immunotherapy of Cancer
|
November 6, 2020
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Alessio Cortellini, Marco Tucci, Vincenzo Adamo, et al.
European Journal of Internal Medicine
|
October 12, 2016
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia
Lorenzo Loffredo, Roberto Cangemi, Ludovica Perri, et al.
Clinical Lung Cancer
|
July 7, 2022
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)
Andrés F Cardona, Alejandro Ruiz-Patiño, Gonzalo Recondo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2025
Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database
Claudio Sini, Alessandro Russo, Diego Cortinovis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 31, 2025
Treatment and follow-up of vascular graft and endograft infection: Delphi consensus document
Ilse J E Kouijzer, Marta Hernández-Meneses, Erik H J G Aarntzen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 26, 2022
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)
Vladmir C Cordeiro de Lima, Marcelo Corassa, Erick Saldanha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 22, 2021
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study
Mario Tumbarello, Francesca Raffaelli, Maddalena Giannella, et al.
The Oncologist
|
December 24, 2025
Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥50%: real-world data from the italian ATLAS registry
Francesco Passiglia, Maria Lucia Reale, Giulia Pasello, et al.
Cancer
|
May 30, 2026
Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry
Francesco Passiglia, Antonio Passaro, Eleonora Gariazzo, et al.
Tumori
|
May 4, 2026
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to <i>KRAS</i> status: An Italian real-world study
Alessandro Leonetti, Vanessa Callegari, Fabiana Perrone, et al.
Page
of 42
Search research articles
Search
Showing results (391-400 of 419) with videos related to
Sort By:
Page
of 42
Journal for Immunotherapy of Cancer
|
November 6, 2020
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Alessio Cortellini, Marco Tucci, Vincenzo Adamo, et al.
European Journal of Internal Medicine
|
October 12, 2016
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia
Lorenzo Loffredo, Roberto Cangemi, Ludovica Perri, et al.
Clinical Lung Cancer
|
July 7, 2022
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)
Andrés F Cardona, Alejandro Ruiz-Patiño, Gonzalo Recondo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2025
Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database
Claudio Sini, Alessandro Russo, Diego Cortinovis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 31, 2025
Treatment and follow-up of vascular graft and endograft infection: Delphi consensus document
Ilse J E Kouijzer, Marta Hernández-Meneses, Erik H J G Aarntzen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 26, 2022
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)
Vladmir C Cordeiro de Lima, Marcelo Corassa, Erick Saldanha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 22, 2021
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study
Mario Tumbarello, Francesca Raffaelli, Maddalena Giannella, et al.
The Oncologist
|
December 24, 2025
Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥50%: real-world data from the italian ATLAS registry
Francesco Passiglia, Maria Lucia Reale, Giulia Pasello, et al.
Cancer
|
May 30, 2026
Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry
Francesco Passiglia, Antonio Passaro, Eleonora Gariazzo, et al.
Tumori
|
May 4, 2026
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to <i>KRAS</i> status: An Italian real-world study
Alessandro Leonetti, Vanessa Callegari, Fabiana Perrone, et al.
Page
of 42